Skip to main content
. Author manuscript; available in PMC: 2010 Nov 23.
Published in final edited form as: J Neurosci. 2009 Nov 25;29(47):14965–14979. doi: 10.1523/JNEUROSCI.3794-09.2009

Table 4. Loss of dorsal CST axons in the lumbar spinal cords of MOG peptide EAE mice is bilaterally symmetric.

EYFP+ axons were counted in the right and left dorsal corticospinal tracts in L3 spinal cord cross-sections from normal, CFA control and MOG peptide EAE EmxCre/RosaSTOP-EYFP mice. The regression coefficient r2 was close to 1 in each group, indicating little variance between the axon counts on the right and left side in either the control or MOG peptide EAE mice (Snedecor and Cochran, 1989).

Days post-
MOG peptide		 Treatment Right Left r2
Normal Untreated 2823 2945
35 CFA 1 3116 3010
101 CFA 1 2830 3069
101 CFA 2 2937 3120
0.997
35 MOG peptide 1 1982 2329
35 MOG peptide 2 1804 1955
35 MOG peptide 3 1819 1489
35 MOG peptide 4 1593 1937
35 MOG peptide 5 702 979
35 MOG peptide 6 1776 1659
0.974
101 MOG peptide 7 275 307
101 MOG peptide 8 247 215
101 MOG peptide 9 397 536
101 MOG peptide 10 1870 1335
0.956